1 Brodntz FS.Spasmodic dysphornia[J].Ann Otol Rhinol lar-yngol,1976,85:210.

2杨宝琦,主编.耳鼻咽喉科学新进展[M].天津:天津科学技术出版社,2002,228～230.

3杨式麟,主编.嗓音医学基础与临床[M].沈阳:辽宁科学技术出版社,2001,498～501.

4 Hartrana D,Abbs JH,Viswanat B.Clinical investigation ad-ductor spasmodic dysphornia[J].Ann Otol Rhinol Laryngol,1998,97:297.

5 Jankovic J,Ford J.Blepharospasm and orofacial-cervical dystonia:clinical and pharmacologic findings in 100patients[J].Ann Neurol,1983,13:402.

6 Dedo HH,Behian MA.Recurent laryngeal nerve section for spasmodic dysphonia:8～14years preliminary results in the first 300patients[J].Ann Otol Rhlol Laryngl,1991,100:274.

7 Green DC,Berke GS.An in vivo canine model for testing treatment efects in laryngeal hyperadduction disorders[J].La-ryngoscope,1990,100:1 229.

8 Becchino JV,Tucker HM.Recurrent nerve pathology in spas-modic dysphonia[J].Laryngoscope,1978,88:1 274.

9 Simonyan K.Brainstem pathology in spasmodic dysphonia[J].Laryngoscope,2010,120:121.

10 Oh J,Park KD,Cho HJ,et al.Spasmodic dysphonia induced by valproic acid[J].Epilepsia,2004,45:880.

11 Btitzer A,Brin MF,Fahn S.Clinieal and laboratory characte-ristics of focal laryngeal dysphonia-a study of 110cases[J].Laryngscope,1988,98:636.

12 Bliter A,Brin ME.Laryngeal dystonia:a series with botuti-num toxin therapy[J].Ann Otol Rhlnol Laryngol,1991,100:85.

13 Schweinfurth JM,Billante M,Courey MS.Risk factors and demographics in patients with spasmodic dysphonia[J].La-ryngoscope,2002,112:220.

14 Btitzer A,Brin MF,Stewant C,et al.Abductor laryngeal dysphonia:A series treated with botulinum toxin[J].Laryn-goscope,1998,102:103.

15 Cyrus CB,Bielamowicz S,Evans FJ,et al.Adductor muscle activity abnormalities in abductor spasmodic dysphonia[J].Otolaryngol Head Neck Surg,2001,124:23.

16徐文,韩德民,侯丽珍,等.痉挛性发音障碍诊断及治疗的研究[J].中华耳鼻咽喉头颈外科杂志,2005,40:253.

17 Fuglsang-Fredcriksen A.The utility of interference pattern analysis[J].Muscle Nerve,2000,23:18.

18 Hillel AD.The study of laryngeal muscle activity in normal human subjects and in patients with laryngeal dystonia using multiple fine-wire electromyography[J].Laryngoscope,2001,111:1.

19 Hartl DM,Crevier-Buchman L,Vaissiere J,et al.Phonetic effects of paralytic dysphonia[J].Ann Otol Rhinol Laryngol,2005,114:792.

20王丽萍,张玉富,张澍,等.痉挛性发音障碍的喉功能特点[J].听力学及言语疾病杂志,2001,9:199.

21张松志.痉挛性发音障碍的研究进展[J].国外医学耳鼻咽喉科学分册,1997,21:282.

22熊田政信,小林武夫,牧山清,他.痙攣性発声障害の新しぃ評価法:と音節法モ一テ法[J].音声言語医学,1997,38:88.

23 Silverman FH.Stuttering and other fluency disorders[M].2nd eds.Boston:Allyn&Bacon,1996.31～56.

24 Blitzer A,Brin MF,Stewart CF.Botulinum toxin management of spasmodic dysphonia(laryngeal dystonia):a 12-year expe-rience in more than 900patients[J].Laryngoscope,1998,108:1 435.

25王丽萍,董晶,陈哓秋,等.特发性嗓音震颤的嗓音变化与声学特征分析[J].临床耳鼻咽喉科杂志,2006,20:817.

26 Dolly JO,Black J,Williams RS,et al.Acceptors for botuli-num neurotoxin reside on motor nerve terminals and mediate its internalization[J].Nature,1984,307:457.

27 Blitzer A,Sulica L.Botulinum toxin:Basic science and clini-cal uses in otolaryngology[J].Laryngoscope,2001,111:218.

28 Ford CN,Bless DM,Lowery JD.Indirect laryngoscopic ap-proach for injection of botulinum toxin in spasmodic dyspho-nia[J].Otolaryngol Head Neck Surg,1990,103:752.

29 Davidson BJ,Ludlow CL.Long-term effects of botulinum toxin injection in spasmodic dysphonia[J].Ann Otol Rhinol Laryngol,1998,105:33.

30 Langeveld T,Prost HA,Baatenburg De Jong RJ.Unilateral versus bilateral botulinum toxin injection in adductor spas-modic dysphonia[J].Ann Otol Rhinol Laryngol,1998,107:280.

31 Whurr R,Nye C,Lorch M.Meta-analysis of botulinum toxin treatment of spasmodic dysphonia:a review of 22stu-dies[J].Int J Lang Commum Disord,1998,33(Suppl):327.

32 Benninger MS,Gardner G,Grywalski C.Outcomes of botu-linum toxin treatment for patients with spasmodic dysphonia[J].Arch Otolaryngol Head Neck Surg,2001,127:1 083.

33胡兴越,范正刚,蒋红,等.A型肉毒毒素治疗痉挛性发音障碍[J].中华耳鼻咽喉科杂志,2002,37:466.

34 Hillel AD,Maronian NC,Eaugh PF,et al.Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dys-tonia[J].Ann Otol Rhinol Laryngol,2004,113:341.

35 Davidson BJ.Ludlow CL.Long-term effects of botulinum toxin injection in spasmodic dysphonia[J].Ann Otol Rhino Laryngol,1998,105:33.

36 Zuher M,Sebatd M,Bathien N,et al.Botutinum toxin anti-bodies inpatienta treated with type A botutinum toxin:fre-quenty and significance[J].Neurology,1993,43:1 715.

37 Tsunoda K,Amagai N,Kondou K,et a1.Autologous replacement of the vocal fold:a new surgical approach for adduction type spasmodic dysphonia[J].J Laryngol Otol,2005,119:222.

38朴泽孝治.シンボジゥム痙攣性発声障害治療のEBM:甲状軟骨形成術II型[J].喉頭,2004,16:79.

39渡边雄介.シンボジゥム痙攣性発声障害治療のEBM:内転性痙攣性発声障害に对すゐ兩側甲状披裂筋切除術[J].喉頭,2004,16:74.

40 Koufman JA,Rees CJ,Halum SL,et a1.Treatment of adduc-tor-type spasmodic dysphonia by surgical myectomy:apre-liminary report[J].Ann Otol Rhinol Laryngol,2006,115:97.

41 Chhetri DK,Mendelsohn AH,Blumin JH,et al.Long-term follow-up results of selective laryngeal adductor dener-vation-reinnervation surgery for adductor spasmodic dys-phonia[J].Laryngoscope,2006,116:635.

42 Levine HL,Wood BG,Batza E,et al.Recurrent laryngeal nerve section for spasmodic dysphonia[J].Ann Otol Rhinol Laryngol,1979,88:527.

43崔哲洙,金兰姬,姜宪.喉返神经甲杓肌分支与颈神经襻分支吻合术治疗痉挛性发声障碍一例[J].中华耳鼻咽喉科杂志,2002,8:303.

44 Weed DT,Jewett BS,Rainey C,et al.Long-term follow-up of recurrent laryngeal nerve avulsion for the treatment of spastic dysphonia[J].Ann Otol Rhinol Laryngol,1996,105:592.

45 Berke GS,Blackwell KE,Gerratt BR,et al.Selective laryn-geal adductor denervation-reinnervation:a new surgical treatment for adductor spasmodic dysphonia[J].Ann Otol Rhinol Laryngol,1999,108:227.

46 Klotz DA,Maronian NC,Waugh PF,et al.Fingdings of multiple muscle involvement in a study of 214patients with laryngeal dystonia using fine-wire electromyography[J].Ann Otol Rhinol Laryngol,2004,113:602.

47 Fredman F,Cannito MP,Finitizo-Hieber T.Getting to know spasmodic dysphonia patients[J].Tex J Audio Speech Pathol,1985,10:14.